Back
Viridian Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
VRDN
Viridian Therapeutics, Inc.
Last Price:
$31.92
Seasonality Move:
-0.64%
7 Day Trial
ALL ACCESS PASS
$
7
Viridian Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 1.3% based on the past 11 years of stock performance.
-
Viridian Therapeutics, Inc. has fallen lower in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
-
Is Viridian Therapeutics, Inc. Stock Undervalued?The current Viridian Therapeutics, Inc. [VRDN] share price is $31.92. The Score for VRDN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
VRDN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Viridian Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 1.3% based on the past 11 years of stock performance.
Viridian Therapeutics, Inc. Stock Rating
Buy
59
Viridian Therapeutics, Inc. (VRDN)
is a Buy
Is Viridian Therapeutics, Inc. overpriced?
-
Viridian Therapeutics, Inc. has fallen lower in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Viridian Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
viridiantherapeutics.com
52-Week Data
52-Week High:
34.04
52-Week Low:
9.90
Prediction Charts
Market Cap:
3B
Price in USD:
31.92
Volume:
4.8M
Beta:
1.24
Technical Analysis
SMA50:
27.68
SMA100:
23.37
SMA200:
18.94
52-Wk Change:
70.42%
Stock Predictions
-
Is Viridian Therapeutics, Inc. stock public?Yes, Viridian Therapeutics, Inc. is a publicly traded company.
-
What is the Viridian Therapeutics, Inc. stock quote today?The Viridian Therapeutics, Inc. stock price is 31.92 USD today.
-
How to buy Viridian Therapeutics, Inc. stock online?You can buy Viridian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 31.53 | 30.43 | 31.94 | 30.22 |
| Dec-3 | 30.97 | 31.30 | 31.65 | 30.68 |
| Dec-4 | 31.30 | 32.46 | 33.34 | 30.91 |
| Dec-5 | 32.44 | 32.02 | 32.97 | 31.95 |
| Dec-8 | 32.60 | 31.88 | 32.87 | 31.71 |
| Dec-9 | 31.42 | 31.80 | 32.32 | 31.11 |
| Dec-10 | 31.90 | 32.60 | 33.23 | 31.62 |
| Dec-11 | 32.71 | 32.57 | 33.29 | 32.46 |
| Dec-12 | 32.69 | 32.31 | 33.05 | 32.29 |
| Dec-15 | 33.67 | 33.03 | 34.04 | 32.72 |
| Dec-16 | 32.68 | 32.85 | 33.49 | 32.27 |
| Dec-17 | 32.65 | 32.13 | 33.52 | 31.98 |
| Dec-18 | 32.15 | 31.60 | 32.27 | 31.20 |
| Dec-19 | 31.75 | 31.92 | 32.88 | 31.63 |
Viridian Therapeutics, Inc. Earnings
Viridian Therapeutics, Inc. Earnings Report: Per Share Viridian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viridian Therapeutics, Inc. Forecast Revenue Growth
Viridian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viridian Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.02 per share.
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.